NSG 6001 Week 2 Quiz - Advanced Pharmacology (2026/2027) 100% Correct Edition
NSG 6001 WEEK 2 QUIZ, 100% CORRECT
2026/2027
Advanced Pharmacology Comprehensive Assessment
Graduate Nursing Education & Advanced Practice Nursing
NSG 6001 - Pharmacology for Advanced Practice Nurses
50-Question Comprehensive Examination - 2026/2027 Edition
Section Topic Questions
1 Pharmacokinetics & Pharmacodynamics 15
2 Drug Interactions & Adverse Reactions 12
3 Prescribing for Special Populations 10
4 Legal, Ethical, & Regulatory Issues 8
5 Evidence-Based Pharmacotherapy 5
Total Comprehensive Assessment 50
This Week 2 comprehensive assessment is designed for graduate-level advanced practice nursing students enrolled in
NSG 6001: Pharmacology for Advanced Practice Nurses. The 50 items are aligned with the NSG 6001 course
syllabus, advanced pharmacology curriculum standards, and current evidence-based prescribing guidelines
(2026/2027). Cognitive distribution is approximately 20% recall, 50% application, and 30% analysis. Approximately
75% of items are scenario-based clinical prescribing questions, and 25% are direct-knowledge items. Each question
provides a detailed rationale linking the correct answer to advanced pharmacology standards, NSG 6001 curriculum
objectives, and patient safety considerations.
Section 1: Pharmacokinetics & Pharmacodynamics
*Q1:* A 62-year-old patient is prescribed oral propranolol 40 mg for hypertension. After
administration, only approximately 25% of the dose reaches systemic circulation. Which
pharmacokinetic concept best explains this phenomenon?
A. Reduced gastric emptying due to beta-blockade
B. First-pass hepatic metabolism in the liver *[CORRECT]*
C. Decreased protein binding in plasma
D. Increased renal tubular reabsorption
Correct Answer: B
Rationale: First-pass effect (presystemic metabolism) occurs when oral drugs are substantially metabolized by hepatic enzymes
before reaching systemic circulation, drastically reducing bioavailability for drugs like propranolol, morphine, and lidocaine.
The other options describe unrelated processes that do not explain the pronounced loss of drug between GI absorption and
systemic availability.
Graduate Nursing Education - NSG 6001 Page 1
, NSG 6001 Week 2 Quiz - Advanced Pharmacology (2026/2027) 100% Correct Edition
*Q2:* Which statement by an NP student about bioavailability is most accurate and reflects NSG
6001 advanced pharmacology standards?
A. Bioavailability is 100% for all orally administered drugs.
B. Bioavailability refers only to the rate of drug absorption.
C. Bioavailability is the fraction of administered drug reaching systemic circulation unchanged *[CORRECT]*
D. Intramuscular bioavailability is always lower than oral bioavailability.
Correct Answer: C
Rationale: Bioavailability is defined as the fraction (or percentage) of an administered dose that reaches the systemic circulation
unchanged and is available at the site of action. IV bioavailability is 100% by definition; oral is reduced by first-pass
metabolism; IM generally exceeds oral but is route- and drug-specific.
*Q3:* A drug has a half-life of 12 hours. The NP plans to administer it twice daily. Approximately
how long will it take to reach steady-state plasma concentration?
A. 12 hours
B. 24 hours
C. 48 to 60 hours *[CORRECT]*
D. 7 days
Correct Answer: C
Rationale: Steady-state is achieved after 4 to 5 half-lives. With a 12-hour half-life, steady-state occurs at 48 to 60 hours.
Selecting 24 hours underestimates the timeframe, while 7 days overestimates it. This principle guides dosing interval decisions
and timing of therapeutic drug monitoring.
*Q4:* A patient with hypoalbuminemia (albumin 2.0 g/dL) is started on warfarin. Which
pharmacokinetic consequence must the APRN anticipate?
A. Decreased volume of distribution and increased free drug fraction *[CORRECT]*
B. Increased protein binding and reduced drug effect
C. Decreased free drug fraction requiring dose increase
D. No change because warfarin does not bind albumin
Correct Answer: A
Rationale: Warfarin is highly albumin-bound; hypoalbuminemia reduces protein binding sites, increasing the free
(pharmacologically active) drug fraction and risk of toxicity. This raises the effective volume of distribution per unit dose.
Increased free fraction mandates dose reduction and closer INR monitoring rather than dose escalation.
*Q5:* Which pathway best describes Phase I drug metabolism in the hepatic CYP450 system?
A. Conjugation with glucuronic acid or sulfate
B. Oxidation, reduction, and hydrolysis reactions *[CORRECT]*
C. Renal tubular secretion of unchanged drug
D. Active transport across the blood-brain barrier
Correct Answer: B
Rationale: Phase I metabolism introduces or exposes functional groups via oxidation, reduction, and hydrolysis, primarily
catalyzed by CYP450 isoenzymes. Phase II involves conjugation (glucuronidation, sulfation, acetylation). Renal secretion and
active transport are elimination and distribution processes, not hepatic Phase I metabolism.
Graduate Nursing Education - NSG 6001 Page 2
NSG 6001 WEEK 2 QUIZ, 100% CORRECT
2026/2027
Advanced Pharmacology Comprehensive Assessment
Graduate Nursing Education & Advanced Practice Nursing
NSG 6001 - Pharmacology for Advanced Practice Nurses
50-Question Comprehensive Examination - 2026/2027 Edition
Section Topic Questions
1 Pharmacokinetics & Pharmacodynamics 15
2 Drug Interactions & Adverse Reactions 12
3 Prescribing for Special Populations 10
4 Legal, Ethical, & Regulatory Issues 8
5 Evidence-Based Pharmacotherapy 5
Total Comprehensive Assessment 50
This Week 2 comprehensive assessment is designed for graduate-level advanced practice nursing students enrolled in
NSG 6001: Pharmacology for Advanced Practice Nurses. The 50 items are aligned with the NSG 6001 course
syllabus, advanced pharmacology curriculum standards, and current evidence-based prescribing guidelines
(2026/2027). Cognitive distribution is approximately 20% recall, 50% application, and 30% analysis. Approximately
75% of items are scenario-based clinical prescribing questions, and 25% are direct-knowledge items. Each question
provides a detailed rationale linking the correct answer to advanced pharmacology standards, NSG 6001 curriculum
objectives, and patient safety considerations.
Section 1: Pharmacokinetics & Pharmacodynamics
*Q1:* A 62-year-old patient is prescribed oral propranolol 40 mg for hypertension. After
administration, only approximately 25% of the dose reaches systemic circulation. Which
pharmacokinetic concept best explains this phenomenon?
A. Reduced gastric emptying due to beta-blockade
B. First-pass hepatic metabolism in the liver *[CORRECT]*
C. Decreased protein binding in plasma
D. Increased renal tubular reabsorption
Correct Answer: B
Rationale: First-pass effect (presystemic metabolism) occurs when oral drugs are substantially metabolized by hepatic enzymes
before reaching systemic circulation, drastically reducing bioavailability for drugs like propranolol, morphine, and lidocaine.
The other options describe unrelated processes that do not explain the pronounced loss of drug between GI absorption and
systemic availability.
Graduate Nursing Education - NSG 6001 Page 1
, NSG 6001 Week 2 Quiz - Advanced Pharmacology (2026/2027) 100% Correct Edition
*Q2:* Which statement by an NP student about bioavailability is most accurate and reflects NSG
6001 advanced pharmacology standards?
A. Bioavailability is 100% for all orally administered drugs.
B. Bioavailability refers only to the rate of drug absorption.
C. Bioavailability is the fraction of administered drug reaching systemic circulation unchanged *[CORRECT]*
D. Intramuscular bioavailability is always lower than oral bioavailability.
Correct Answer: C
Rationale: Bioavailability is defined as the fraction (or percentage) of an administered dose that reaches the systemic circulation
unchanged and is available at the site of action. IV bioavailability is 100% by definition; oral is reduced by first-pass
metabolism; IM generally exceeds oral but is route- and drug-specific.
*Q3:* A drug has a half-life of 12 hours. The NP plans to administer it twice daily. Approximately
how long will it take to reach steady-state plasma concentration?
A. 12 hours
B. 24 hours
C. 48 to 60 hours *[CORRECT]*
D. 7 days
Correct Answer: C
Rationale: Steady-state is achieved after 4 to 5 half-lives. With a 12-hour half-life, steady-state occurs at 48 to 60 hours.
Selecting 24 hours underestimates the timeframe, while 7 days overestimates it. This principle guides dosing interval decisions
and timing of therapeutic drug monitoring.
*Q4:* A patient with hypoalbuminemia (albumin 2.0 g/dL) is started on warfarin. Which
pharmacokinetic consequence must the APRN anticipate?
A. Decreased volume of distribution and increased free drug fraction *[CORRECT]*
B. Increased protein binding and reduced drug effect
C. Decreased free drug fraction requiring dose increase
D. No change because warfarin does not bind albumin
Correct Answer: A
Rationale: Warfarin is highly albumin-bound; hypoalbuminemia reduces protein binding sites, increasing the free
(pharmacologically active) drug fraction and risk of toxicity. This raises the effective volume of distribution per unit dose.
Increased free fraction mandates dose reduction and closer INR monitoring rather than dose escalation.
*Q5:* Which pathway best describes Phase I drug metabolism in the hepatic CYP450 system?
A. Conjugation with glucuronic acid or sulfate
B. Oxidation, reduction, and hydrolysis reactions *[CORRECT]*
C. Renal tubular secretion of unchanged drug
D. Active transport across the blood-brain barrier
Correct Answer: B
Rationale: Phase I metabolism introduces or exposes functional groups via oxidation, reduction, and hydrolysis, primarily
catalyzed by CYP450 isoenzymes. Phase II involves conjugation (glucuronidation, sulfation, acetylation). Renal secretion and
active transport are elimination and distribution processes, not hepatic Phase I metabolism.
Graduate Nursing Education - NSG 6001 Page 2
